PMID- 11063817 OWN - NLM STAT- MEDLINE DCOM- 20001222 LR - 20190826 IS - 0165-5728 (Print) IS - 0165-5728 (Linking) VI - 111 IP - 1-2 DP - 2000 Nov 1 TI - A role for adrenoceptors in the regulation of pleural neutrophilia induced by LPS. PG - 15-22 AB - The role of catecholamines in regulating pleural neutrophilia evoked by intrathoracic (i.t.) injection of lipopolysaccharide (LPS) was investigated in Wistar rats by means of surgical adrenalectomy, depletion of catecholamine stores or adrenoceptor blockade. Treatment of animals with a single dose of LPS evoked a dramatic increase in the number of pleural neutrophils concomitant with an increase in the number of these cells in blood at 4 h. Although blood neutrophilia was drastically reduced when catecholamine stores were depleted with intraperitoneal (i.p.) injection of reserpine, pleural neutrophilia was not modified. However, the i.t. injection of reserpine reduced the increase in pleural neutrophils after LPS stimulation. Adrenalectomy failed to inhibit the increase in neutrophil counts in the blood or pleural cavity after LPS challenge. Pretreatment with intravenous (i.v.) injection of prazosin, an alpha(1)/alpha(2B) antagonist, reduced LPS-induced blood but not pleural neutrophilia. On the other hand, although pleural neutrophilia was not affected by systemic pretreatment with the alpha(2)-adrenoceptor antagonist, yohimbine, the local treatment (i. t. injection) with this antagonist markedly reduced the increase in pleural neutrophil counts observed after stimulation by LPS. In contrast, pleural neutrophilia induced by i.t injection of formyl-methionyl-leucyl-phenylalanine (fMLP) was not modified by local treatment with yohimbine. Taken together, our results suggest that catecholamines, through activation of alpha(1) and alpha(2)-adrenoceptors, play a role in the regulation of blood and pleural neutrophilia observed during the inflammatory response evoked by LPS in the pleural cavity. FAU - Altenburg, S P AU - Altenburg SP AD - Nucleo de Ciencias Comportamentais e do Desenvolvimento, Departamento de Fisiologia e Farmacologia, Instituto Biomedico, Universidade Federal Fluminense (UFF), Rua Ernani Melo 101, S. Domingos, 24210-130, Niteroi, Brazil. FAU - Paixao e Silva, S AU - Paixao e Silva S FAU - Ventura, D G AU - Ventura DG FAU - Gomes, R N AU - Gomes RN FAU - Bozza, P T AU - Bozza PT FAU - Castro-Faria-Neto, H C AU - Castro-Faria-Neto HC LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Netherlands TA - J Neuroimmunol JT - Journal of neuroimmunology JID - 8109498 RN - 0 (Adrenergic Uptake Inhibitors) RN - 0 (Adrenergic alpha-Antagonists) RN - 0 (Catecholamines) RN - 0 (Lipopolysaccharides) RN - 0 (Receptors, Adrenergic) RN - 2Y49VWD90Q (Yohimbine) RN - 59880-97-6 (N-Formylmethionine Leucyl-Phenylalanine) RN - 8B1QWR724A (Reserpine) SB - IM MH - Adrenalectomy MH - Adrenergic Uptake Inhibitors/pharmacology MH - Adrenergic alpha-Antagonists/pharmacology MH - Animals MH - Catecholamines/metabolism MH - Chemotaxis, Leukocyte/drug effects/immunology MH - Lipopolysaccharides/*pharmacology MH - Male MH - N-Formylmethionine Leucyl-Phenylalanine/pharmacology MH - Neutrophils/cytology/*immunology MH - Pleura/chemistry/cytology/drug effects/*immunology MH - Pleurisy/chemically induced/immunology MH - Rats MH - Rats, Wistar MH - Receptors, Adrenergic/*immunology/metabolism MH - Reserpine/pharmacology MH - Yohimbine/pharmacology EDAT- 2000/11/07 11:00 MHDA- 2001/02/28 10:01 CRDT- 2000/11/07 11:00 PHST- 2000/11/07 11:00 [pubmed] PHST- 2001/02/28 10:01 [medline] PHST- 2000/11/07 11:00 [entrez] AID - S0165572800003763 [pii] AID - 10.1016/s0165-5728(00)00376-3 [doi] PST - ppublish SO - J Neuroimmunol. 2000 Nov 1;111(1-2):15-22. doi: 10.1016/s0165-5728(00)00376-3.